Altamira Therapeutics Ltd. Income Tax Expense Continuing Operations
Altamira Therapeutics Ltd. (CYTOF) reported Income Tax Expense Continuing Operations of CHF 10.60 thousand for the 6-month period ending 2023-06-30, per its 6-K filed 2023-09-12.
Financial Statements › Expense Statement › Income Tax
ifrs-full:IncomeTaxExpenseContinuingOperations · last filed 2025-04-30
CHF
| Period end | Income Tax Expense Continuing Operations 6 month | Income Tax Expense Continuing Operations 12 month | Income Tax Expense Continuing Operations 12 month as first filed |
|---|---|---|---|
| 2023-06-30 | 10.60K CHF 6-K · filed 2023-09-12 | ||
| 2022-12-31 | -7.92K CHF 20-F/A · filed 2024-04-22 | -10.33K CHF 20-F · filed 2023-05-16 | |
| 2022-06-30 | -46.09K CHF 6-K · filed 2023-09-12 | ||
| 2021-12-31 | -117.94K CHF 20-F/A · filed 2024-04-22 | 21.62K CHF 20-F · filed 2022-04-12 | |
| 2021-06-30 | -10.64K CHF 6-K/A · filed 2023-08-21 | ||
| 2020-12-31 | -21.28K CHF 20-F · filed 2023-05-16 | ||
| 2020-06-30 | -10.64K CHF 6-K · filed 2021-09-08 | ||
| 2019-12-31 | -193.84K CHF 20-F · filed 2022-04-12 | ||
| 2019-06-30 | -261.39K CHF 6-K/A · filed 2020-09-17 | ||
| 2018-12-31 | 162.18K CHF 20-F · filed 2021-03-31 | ||
| 2018-06-30 | -17.45K CHF 6-K · filed 2019-08-15 | ||
| 2017-12-31 | -17.77K CHF 20-F · filed 2020-04-16 | ||
| 2016-12-31 | -131.06K CHF 20-F · filed 2019-03-14 | ||
| 2015-12-31 | 0.00 CHF 20-F · filed 2018-03-22 |
USD
| Period end | Income Tax Expense Continuing Operations 12 month | Income Tax Expense Continuing Operations 12 month as first filed |
|---|---|---|
| 2022-12-31 | -$8.29K 20-F · filed 2025-04-30 | $7.92K 20-F/A · filed 2024-04-22 |
| 2021-12-31 | $117.94K 20-F/A · filed 2024-04-22 |